Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV

Daniel D Murray; Birgit Grund; Cameron MacPherson; Christina Ekenberg; Adrian Zucco; Joanne Reekie; Lourdes Dominguez-Dominguez; Preston Leung; Dahlene Fusco; Julien Gras; Jan Gerstoft; Marie Helleberg; Álvaro H Borges; Mark Polizzotto; Jens D Lundgren; INSIGHT START, SMART, ESPRIT, STALWART study groups, the FIRST study group

doi:10.1097/QAD.0000000000003427

Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV

Daniel D Murray, Birgit Grund, Cameron MacPherson, Christina Ekenberg, Adrian Zucco, Joanne Reekie, Lourdes Dominguez-Dominguez, Preston Leung, Dahlene Fusco, Julien Gras, Jan Gerstoft, Marie Helleberg, Álvaro H Borges, Mark Polizzotto, Jens D Lundgren, INSIGHT START, SMART, ESPRIT, STALWART study groups, the FIRST study group

Afdeling for Infektionssygdomme

Abstrakt

INTRODUCTION: Identifying genetic factors that influence HIV-pathogenesis is critical for understanding disease pathways. Previous studies have suggested a role for the human gene ten-eleven methylcytosine dioxygenase 2 (TET2) in modulating HIV-pathogenesis.

METHODS: We assessed whether genetic variation in TET2 was associated with markers of HIV-pathogenesis using both gene level and single nucleotide polymorphism (SNP) level association in 8512 HIV-positive persons across five clinical trial cohorts.

RESULTS: Variation at both the gene and SNP-level of TET2 was found to be associated with levels of HIV viral load (HIV-VL) consistently in the two cohorts that recruited antiretroviral-naïve participants. The SNPs occurred in two clusters of high linkage disequilibrium (LD), one associated with high HIV-VL and the other low HIV-VL, and were predominantly found in Black participants.

CONCLUSION: Genetic variation in TET2 was associated with HIV-VL in two large antiretroviral therapy (ART)-naive clinical trial cohorts. The role of TET2 in HIV-pathogenesis warrants further investigation.

Originalsprog	Engelsk
Tidsskrift	AIDS
Vol/bind	37
Udgave nummer	3
Sider (fra-til)	379-387
Antal sider	9
ISSN	0269-9370
DOI	https://doi.org/10.1097/QAD.0000000000003427
Status	Udgivet - 1 mar. 2023

Adgang til dokumentet

10.1097/QAD.0000000000003427

Andre filer og links

Link to publication in Scopus

Citationsformater

Murray, D. D., Grund, B., MacPherson, C., Ekenberg, C., Zucco, A., Reekie, J., Dominguez-Dominguez, L., Leung, P., Fusco, D., Gras, J., Gerstoft, J., Helleberg, M., Borges, Á. H., Polizzotto, M., Lundgren, J. D., & INSIGHT START, SMART, ESPRIT, STALWART study groups, the FIRST study group (2023). Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV. AIDS, 37(3), 379-387. https://doi.org/10.1097/QAD.0000000000003427

Murray, DD, Grund, B, MacPherson, C, Ekenberg, C, Zucco, A , Reekie, J , Dominguez-Dominguez, L , Leung, P, Fusco, D, Gras, J, Gerstoft, J , Helleberg, M , Borges, ÁH, Polizzotto, M, Lundgren, JD & INSIGHT START, SMART, ESPRIT, STALWART study groups, the FIRST study group 2023, 'Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV', AIDS, bind 37, nr. 3, s. 379-387. https://doi.org/10.1097/QAD.0000000000003427

@article{c5549fd0e9ae499dae533fdd9c1d424b,

title = "Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV",

abstract = "INTRODUCTION: Identifying genetic factors that influence HIV-pathogenesis is critical for understanding disease pathways. Previous studies have suggested a role for the human gene ten-eleven methylcytosine dioxygenase 2 (TET2) in modulating HIV-pathogenesis.METHODS: We assessed whether genetic variation in TET2 was associated with markers of HIV-pathogenesis using both gene level and single nucleotide polymorphism (SNP) level association in 8512 HIV-positive persons across five clinical trial cohorts.RESULTS: Variation at both the gene and SNP-level of TET2 was found to be associated with levels of HIV viral load (HIV-VL) consistently in the two cohorts that recruited antiretroviral-na{\"i}ve participants. The SNPs occurred in two clusters of high linkage disequilibrium (LD), one associated with high HIV-VL and the other low HIV-VL, and were predominantly found in Black participants.CONCLUSION: Genetic variation in TET2 was associated with HIV-VL in two large antiretroviral therapy (ART)-naive clinical trial cohorts. The role of TET2 in HIV-pathogenesis warrants further investigation.",

keywords = "CD4 Lymphocyte Count, Dioxygenases/genetics, HIV Infections/drug therapy, Humans, Polymorphism, Single Nucleotide, Viral Load",

author = "Murray, {Daniel D} and Birgit Grund and Cameron MacPherson and Christina Ekenberg and Adrian Zucco and Joanne Reekie and Lourdes Dominguez-Dominguez and Preston Leung and Dahlene Fusco and Julien Gras and Jan Gerstoft and Marie Helleberg and Borges, {{\'A}lvaro H} and Mark Polizzotto and Lundgren, {Jens D} and {INSIGHT START, SMART, ESPRIT, STALWART study groups, the FIRST study group}",

note = "Copyright {\textcopyright} 2022 The Author(s). Published by Wolters Kluwer Health, Inc.",

year = "2023",

month = mar,

day = "1",

doi = "10.1097/QAD.0000000000003427",

language = "English",

volume = "37",

pages = "379--387",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams & Wilkins",

number = "3",

}

TY - JOUR

T1 - Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV

AU - Murray, Daniel D

AU - Grund, Birgit

AU - MacPherson, Cameron

AU - Ekenberg, Christina

AU - Zucco, Adrian

AU - Reekie, Joanne

AU - Dominguez-Dominguez, Lourdes

AU - Leung, Preston

AU - Fusco, Dahlene

AU - Gras, Julien

AU - Gerstoft, Jan

AU - Helleberg, Marie

AU - Borges, Álvaro H

AU - Polizzotto, Mark

AU - Lundgren, Jens D

AU - INSIGHT START, SMART, ESPRIT, STALWART study groups, the FIRST study group

PY - 2023/3/1

Y1 - 2023/3/1

N2 - INTRODUCTION: Identifying genetic factors that influence HIV-pathogenesis is critical for understanding disease pathways. Previous studies have suggested a role for the human gene ten-eleven methylcytosine dioxygenase 2 (TET2) in modulating HIV-pathogenesis.METHODS: We assessed whether genetic variation in TET2 was associated with markers of HIV-pathogenesis using both gene level and single nucleotide polymorphism (SNP) level association in 8512 HIV-positive persons across five clinical trial cohorts.RESULTS: Variation at both the gene and SNP-level of TET2 was found to be associated with levels of HIV viral load (HIV-VL) consistently in the two cohorts that recruited antiretroviral-naïve participants. The SNPs occurred in two clusters of high linkage disequilibrium (LD), one associated with high HIV-VL and the other low HIV-VL, and were predominantly found in Black participants.CONCLUSION: Genetic variation in TET2 was associated with HIV-VL in two large antiretroviral therapy (ART)-naive clinical trial cohorts. The role of TET2 in HIV-pathogenesis warrants further investigation.

AB - INTRODUCTION: Identifying genetic factors that influence HIV-pathogenesis is critical for understanding disease pathways. Previous studies have suggested a role for the human gene ten-eleven methylcytosine dioxygenase 2 (TET2) in modulating HIV-pathogenesis.METHODS: We assessed whether genetic variation in TET2 was associated with markers of HIV-pathogenesis using both gene level and single nucleotide polymorphism (SNP) level association in 8512 HIV-positive persons across five clinical trial cohorts.RESULTS: Variation at both the gene and SNP-level of TET2 was found to be associated with levels of HIV viral load (HIV-VL) consistently in the two cohorts that recruited antiretroviral-naïve participants. The SNPs occurred in two clusters of high linkage disequilibrium (LD), one associated with high HIV-VL and the other low HIV-VL, and were predominantly found in Black participants.CONCLUSION: Genetic variation in TET2 was associated with HIV-VL in two large antiretroviral therapy (ART)-naive clinical trial cohorts. The role of TET2 in HIV-pathogenesis warrants further investigation.

KW - CD4 Lymphocyte Count

KW - Dioxygenases/genetics

KW - HIV Infections/drug therapy

KW - Humans

KW - Polymorphism, Single Nucleotide

KW - Viral Load

UR - http://www.scopus.com/inward/record.url?scp=85147047839&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000003427

DO - 10.1097/QAD.0000000000003427

M3 - Journal article

C2 - 36473831

VL - 37

SP - 379

EP - 387

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 3

ER -

Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV

Abstrakt

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater